Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Interleukin 12Interleukin 23BiomarkerDiagnosisCrohn Disease
Interventions
PROCEDURE

Immunohistochemistry procedure

"Briefly, all slides will be rehydrated, and antigen retrieval will be performed using sodium citrate (pH = 6.0) in a pressure cooker (EDTA buffer, pH = 8.4).~All slides will be blocked with endogenous peroxidase with 3% hydrogen peroxide and blocked non-specific protein with 2.5% bovine serum albumin in phosphate-buffered saline.~If the result shows non-specific ileitis, immunohistochemical staining for IL-12 and IL-23 will be performed using sandwich enzyme-linked immunosorbent assays (ELISA)."

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06844565 - Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease | Biotech Hunter | Biotech Hunter